Cited by 182Osteoarthritis Treatment and MechanismsProteoglycans and glycosaminoglycans researchProtease and Inhibitor Mechanisms

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; none of the 28 sources its claims cite is checked for support yet.

Arthropod steroid hormone (20-Hydroxyecdysone) suppresses IL-1β- induced catabolic gene expression in cartilage

Open access
Sheu, Shiow-Yunn, Ho, Shin-Rong, Sun, Jui-Sheng, Chen, Ching-Yun, Ke, Cherng-Jyh·2015·BMC Complementary and Alternative Medicine

Abstract

BACKGROUND: In osteoarthritis (OA), the imbalance of chondrocytes' anabolic and catabolic factors can induce cartilage destruction. Interleukin-1 beta (IL-1β) is a potent pro-inflammatory cytokine that is capable of inducing chondrocytes and synovial cells to synthesize MMPs. The hypoxia-inducible factor-2alpha (HIF-2alpha, encoded by Epas1) is the catabolic transcription factor in the osteoarthritic process. The purpose of this study is to validate the effects of ecdysteroids (Ecd) on IL-1β-induced cartilage catabolism and the possible role of Ecd in treatment or prevention of early OA. METHODS: Chondrocytes and articular cartilage was harvested from newborn ICR mice. Ecd effect on chondrocytes viability was tested and the optimal concentration was determined by MTT assay. The effect of HIF-2α (EPAS1) in cartilage catabolism simulated by IL-1β (5 ng/ml) was evaluated by articular cartilage explants culture. The effects of Ecd on IL-1β-induced inflammatory conditions and their related catabolic genes expression were analyzed. RESULTS: Interleukin-1β (IL-1β) treatment on primary mouse articular cartilage explants enhanced their Epas1, matrix metalloproteinases (MMP-3, MMP-13) and ADAMTS-5 genes expression and down-regulated collagen type II (Col2a1) gene expression. With the pre-treatment of 10(-8) M Ecd, the catabolic effects of IL-1β on articular cartilage were scavenged. CONCLUSION: In conclusions, Ecd can reduce the IL-1β-induced inflammatory effect of the cartilage. Ecd may suppress IL-1β-induced cartilage catabolism via HIF-2α pathway.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

In newborn ICR mouse chondrocytes and articular cartilage explants, IL-1β (5 ng/ml) increased Epas1, MMP-3, MMP-13, and ADAMTS-5 and decreased Col2a1; pretreatment with 10−8 M 20-hydroxyecdysone suppressed these catabolic changes. The authors conclude that Ecd has chondroprotective effects via the HIF-2α pathway, but call for further in vivo and translational work.

Key findings

  • Ecd enhanced chondrocyte viability, with maximal benefit at 10−8 M after 10 days of culture (p < 0.01); significant differences from control were observed at tested Ecd concentrations (p < 0.05), and 10−8 M was chosen for further experiments.
  • IL-1β treatment enhanced Epas1 mRNA and suppressed Col2a1 in chondrocytes; in articular cartilage explants, IL-1β up-regulated MMP-3, MMP-13, and ADAMTS-5 and down-regulated Col2a1. Pretreatment with 10−8 M Ecd eliminated the IL-1β-enhanced Epas1 expression and down-regulated the catabolic genes, but did not affect Col2a1 in the conditions shown in Figure 2.
  • Under hypoxic conditions (3.5% O2), Epas1 expression was higher; Ecd suppressed IL-1β-induced Epas1 and ADAMTS-5 under both hypoxic and normoxic conditions, while MMP-3 was down-regulated only under normoxic conditions. Under hypoxia, IL-1β-mediated ADAMTS-5 up-regulation was the main catabolic mediator, and no significant MMP13 expression was found (data not shown).

Methods

  • Primary chondrocytes and articular cartilage explants were harvested from newborn ICR mice (3 days old); chondrocytes were isolated by collagenase digestion and cultured. Viability was tested by MTT assay with Ecd at 10−6 to 10−10 M on days 1, 3, 7, and 10 (n = 8).
  • Cartilage explants were pre-incubated with or without Ecd (10−8 M), then treated with IL-1β (5 ng/ml); Ecd was added 24 hours before or after IL-1β, and explants were incubated under hypoxic (3.5% O2) or normoxic conditions.
  • Gene expression was analyzed by RT-PCR for Col2a1, MMP-3, MMP-13, ADAMTS5, EPAS1, and β-actin at 0, 3, 6, 12, 24, and 36 hours after Ecd addition. Experiments were performed at least in triplicate; results were analyzed by two-way ANOVA with Dunnett’s test at p < 0.05.

Limitations

  • The authors state that further in vivo HIF-1alpha gene knock-down and translational medicine studies are mandatory for possible clinical application.
  • Evident from the text: the study is limited to in vitro mouse chondrocyte cultures and articular cartilage explants, with no in vivo osteoarthritis model, protein/activity assays, or histological outcomes reported.
  • Evident from the text: Ecd did not affect Col2a1 in Figure 2, and MMP13 expression under hypoxic conditions was not shown, limiting conclusions about full phenotypic recovery and hypoxic MMP13 involvement.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12906-015-0520-z

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Effect of Ecd and IL-1 beta on chondrocytes. A Ecd treatment enhance chondrocytes viability. Chondrocytes at every concentration proliferate actively, with significant statistical differences observed between chondrocytes treated with Ecd and that of the control. Chondrocytes’ viability reaches its maximal beneficial effect at 10−8M Ecd after 10 days of culture. B and C IL-1β induce HIF-2α (encoded by Epas1) gene expression in chondrocytes. In this study, mouse articular chondrocytes are treated with IL-1β cytokines. The results showed that IL-1β can enhance Epas1 gene expression, while suppress collagen type II (Col2a1) gene expression. (Each value is the mean ± standard deviations; n = 8; *:p<0.05; **:p< 0.01; ***:p < 0.001).
Figure 1 Effect of Ecd and IL-1 beta on chondrocytes. A Ecd treatment enhance chondrocytes viability. Chondrocytes at every concentration proliferate actively, with significant statistical differences observed between chondrocytes treated with Ecd and that of the control. Chondrocytes’ viability reaches its maximal beneficial effect at 10−8M Ecd after 10 days of culture. B and C IL-1β induce HIF-2α (encoded by Epas1) gene expression in chondrocytes. In this study, mouse articular chondrocytes are treated with IL-1β cytokines. The results showed that IL-1β can enhance Epas1 gene expression, while suppress collagen type II (Col2a1) gene expression. (Each value is the mean ± standard deviations; n = 8; *:p<0.05; **:p< 0.01; ***:p < 0.001).CC BY · PubMed Central
Figure 2 Regulatory mechanisms of Epas1 expression in articular cartilage explants under IL-1β treatment. In this study, mouse articular cartilage explants are treated with IL-1β cytokines. The results showed that IL-1β can enhance Epas1 gene expression (A), and suppress collagen type II (Col2a1) gene expression (B). The pretreatment of 10−8M Ecd can effectively eliminate the Epas1 gene expression enhanced by IL-1β treatment. (Each value is the mean ± standard deviations; n = 8; *:p<0.05; **:p< 0.01; ***:p < 0.001).
Figure 2 Regulatory mechanisms of Epas1 expression in articular cartilage explants under IL-1β treatment. In this study, mouse articular cartilage explants are treated with IL-1β cytokines. The results showed that IL-1β can enhance Epas1 gene expression (A), and suppress collagen type II (Col2a1) gene expression (B). The pretreatment of 10−8M Ecd can effectively eliminate the Epas1 gene expression enhanced by IL-1β treatment. (Each value is the mean ± standard deviations; n = 8; *:p<0.05; **:p< 0.01; ***:p < 0.001).CC BY · PubMed Central
Figure 3 Ecd pre-treatment reduce the catabolic effect of IL-1β on the cartilage explants. Treatment of primary cultures of mouse articular cartilage explants with recombinant mouse IL-1β protein specifically induce the expression of MMP3 (A), MMP13 (B) and ADAMTS-5 (C) genes expression; with the pretreatment of 10−8M Ecd, the catabolic factor genes upregulated by IL-1β treatment are eliminated. (Each value is the mean ± standard deviations; n = 8; *:p<0.05; **:p< 0.01; ***:p < 0.001).
Figure 3 Ecd pre-treatment reduce the catabolic effect of IL-1β on the cartilage explants. Treatment of primary cultures of mouse articular cartilage explants with recombinant mouse IL-1β protein specifically induce the expression of MMP3 (A), MMP13 (B) and ADAMTS-5 (C) genes expression; with the pretreatment of 10−8M Ecd, the catabolic factor genes upregulated by IL-1β treatment are eliminated. (Each value is the mean ± standard deviations; n = 8; *:p<0.05; **:p< 0.01; ***:p < 0.001).CC BY · PubMed Central
Figure 4 Ecd protect cartilage explants both in hypoxic and normoxic conditions. The Epas 1 gene expression is enhanced under hypoxic condition. With the pre-treatment of 10−8M Ecd, it can effectively eliminate the IL-1β enhanced Epas1 gene expression (A). The Col2a1 gene expression was stationary under normoxic condition (B). Under hypoxic condition, the pretreatment of 10−8M Ecd can effectively eliminate the IL-1β down-regulated Col2a1 gene expression. Under hypoxic condition, IL-1β mediates HIF-2α–induced ADAMTS-5 gene expression of articular cartilage. The pretreatment of 10−8M Ecd can effectively down-regulate MMP3 gene expression only under normoxic condition (C); while down-regulate ADAMTS5 genes expression both in normoxic and hypoxic conditions (D). (Each value is the mean ± standard deviations; n = 8; *:p<0.05; **:p< 0.01; ***:p < 0.001).
Figure 4 Ecd protect cartilage explants both in hypoxic and normoxic conditions. The Epas 1 gene expression is enhanced under hypoxic condition. With the pre-treatment of 10−8M Ecd, it can effectively eliminate the IL-1β enhanced Epas1 gene expression (A). The Col2a1 gene expression was stationary under normoxic condition (B). Under hypoxic condition, the pretreatment of 10−8M Ecd can effectively eliminate the IL-1β down-regulated Col2a1 gene expression. Under hypoxic condition, IL-1β mediates HIF-2α–induced ADAMTS-5 gene expression of articular cartilage. The pretreatment of 10−8M Ecd can effectively down-regulate MMP3 gene expression only under normoxic condition (C); while down-regulate ADAMTS5 genes expression both in normoxic and hypoxic conditions (D). (Each value is the mean ± standard deviations; n = 8; *:p<0.05; **:p< 0.01; ***:p < 0.001).CC BY · PubMed Central
Figure 5 Molecular mechanism of Ecd chondroprotective effect. Both physical and chemical factors may induce cartilage degradation via IL-1β/ HIF-2α pathway; 20-Hydroxyecdysone (Ecd) does have chondroprotective effect and can inhibit IL-1β- induced cartilage catabolism via HIF-2α pathway.
Figure 5 Molecular mechanism of Ecd chondroprotective effect. Both physical and chemical factors may induce cartilage degradation via IL-1β/ HIF-2α pathway; 20-Hydroxyecdysone (Ecd) does have chondroprotective effect and can inhibit IL-1β- induced cartilage catabolism via HIF-2α pathway.CC BY · PubMed Central

Verification

Claims the paper makes

22 Own result · 15 Not checked yet · 9 Own interpretation · 2 Own method · 1 No basis given

Verify all 28 references — free account

Show all 34 claims

  • The quote only partly states this claim. 1
  • It may state two separate claims as one. 5
  • Probably not a substantial claim. 13
15 of 15
  • The paper relies on this without support.

    Epas1 gene expression is a valid proxy for HIF-2α activity.

    “The hypoxia-inducible factor-2alpha (HIF-2α, encoded by Epas1) is a catabolic transcription factor in the osteoarthritic process.”
  • The paper relies on this without support.

    Findings in mouse articular cartilage explants are relevant to human OA.

    “The purpose of this study is to validate the effects of Ecd on IL-1β- induced cartilage destruction and also the possible role of Ecd in treatment or prevention of early OA.”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Cited by

Sorted by citations

Metadata

Authors
Sheu, S.-Y., Ho, S.-R., Sun, J.-S., Chen, C.-Y., & Ke, C.-J.
Affiliations
  • Taipei Medical University (TW)
  • National Yang Ming Chiao Tung University (TW)
  • National Taiwan University (TW)
Corresponding author
Sun, Jui-Sheng
Venue
BMC Complementary and Alternative Medicine
Published
2015-01-24
Volume
15
Issue
1
Pages
1-1
ISSN
1472-6882 (ISSN-L)
OpenAlex
W2005726309
Cited by
181
References
34
Citations by year
2026: 4 · 2025: 18 · 2024: 15 · 2023: 14 · 2022: 11 · 2021: 29 · 2020: 16 · 2019: 19 · 2018: 17 · 2017: 19 · 2016: 17 · 2015: 2
FWCI
15.36
Type
journal article
Language
en
Open access
Locations
  • BMC Complementary and Alternative Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Science Council
  • National Taiwan University Hospital
  • National Taiwan University
Topics
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Keywords
20-hydroxyecdysone, ecdysteroids, osteoarthritis, cartilage catabolism, IL-1β, HIF-2α, EPAS1, chondrocytes, matrix metalloproteinases, ADAMTS5, type II collagen, articular cartilage, inflammation
MeSH terms
Endothelial PAS Domain-Containing Protein 1, Animals, Arthropods, Cartilage, Cartilage, Articular, Cells, Cultured, Ecdysterone, Male, Mice, Inbred ICR, Osteoarthritis, Synovial Membrane, Transcription Factors, Down-Regulation, Gene Expression, Cytokines, Matrix Metalloproteinase 3, Chondrocytes, Collagen Type II, Basic Helix-Loop-Helix Proteins, Matrix Metalloproteinase 13, Interleukin-1beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review